These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34183204)

  • 1. Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis.
    Sandmann F; Jit M; Andrews N; Buckley HL; Campbell H; Ribeiro S; Sile B; Stowe J; Tessier E; Ramsay M; Amirthalingam G; Choi YH
    Vaccine; 2021 Jul; 39(32):4500-4509. PubMed ID: 34183204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness and programmatic benefits of maternal vaccination against pertussis in England.
    van Hoek AJ; Campbell H; Amirthalingam G; Andrews N; Miller E
    J Infect; 2016 Jul; 73(1):28-37. PubMed ID: 27108802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of pertussis vaccination during pregnancy in Japan.
    Hoshi SL; Seposo X; Okubo I; Kondo M
    Vaccine; 2018 Aug; 36(34):5133-5140. PubMed ID: 30041878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis infant morbidity and mortality trends after universal maternal immunisation in Mexico: An ecological database study with time-series analysis.
    Guzman-Holst A; Luna-Casas G; Cervantes-Apolinar MY; Huerta-Garcia GC; Juliao P; Sánchez-González G
    Vaccine; 2021 Apr; 39(16):2311-2318. PubMed ID: 33773845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Utility Analysis of Universal Maternal Pertussis Immunisation in Thailand: A Comparison of Two Model Structures.
    Botwright S; Win EM; Kapol N; Benjawan S; Teerawattananon Y
    Pharmacoeconomics; 2023 Jan; 41(1):77-91. PubMed ID: 36348154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.
    Sartori AMC; de Soárez PC; Fernandes EG; Gryninger LCF; Viscondi JYK; Novaes HMD
    Vaccine; 2016 Mar; 34(13):1531-1539. PubMed ID: 26899375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of pertussis booster vaccination for preschool children in Japan.
    Tanaka M; Okubo R; Hoshi SL; Ishikawa N; Kondo M
    Vaccine; 2022 Feb; 40(7):1010-1018. PubMed ID: 35039195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis.
    Kandeil W; van den Ende C; Bunge EM; Jenkins VA; Ceregido MA; Guignard A
    Expert Rev Vaccines; 2020 Jul; 19(7):621-638. PubMed ID: 32772755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is adding maternal vaccination to prevent whooping cough cost-effective in Australia?
    Van Bellinghen LA; Dimitroff A; Haberl M; Li X; Manton A; Moeremans K; Demarteau N
    Hum Vaccin Immunother; 2018; 14(9):2263-2273. PubMed ID: 29771574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of maternal pertussis vaccination in England: an observational study.
    Amirthalingam G; Andrews N; Campbell H; Ribeiro S; Kara E; Donegan K; Fry NK; Miller E; Ramsay M
    Lancet; 2014 Oct; 384(9953):1521-8. PubMed ID: 25037990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing adolescent immunization options for pertussis in Canada: A cost-utility analysis.
    Anyiwe K; Richardson M; Brophy J; Sander B
    Vaccine; 2020 Feb; 38(7):1825-1833. PubMed ID: 31889607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review.
    Amirthalingam G; Gupta S; Campbell H
    Euro Surveill; 2013 Sep; 18(38):. PubMed ID: 24084340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Pertussis Mortality Rates Make Maternal Acellular Pertussis Immunization Cost-Effective in Low- and Middle-Income Countries? A Decision Analysis.
    Russell LB; Pentakota SR; Toscano CM; Cosgriff B; Sinha A
    Clin Infect Dis; 2016 Dec; 63(suppl 4):S227-S235. PubMed ID: 27838677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis vaccination in pregnancy in Canada: a cost-utility analysis.
    Abu-Raya B; Coyle D; Bettinger JA; Vaudry W; Halperin SA; Sadarangani M;
    CMAJ Open; 2020; 8(4):E651-E658. PubMed ID: 33077536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalisation of preterm infants with pertussis in the context of a maternal vaccination programme in England.
    Byrne L; Campbell H; Andrews N; Ribeiro S; Amirthalingam G
    Arch Dis Child; 2018 Mar; 103(3):224-229. PubMed ID: 28814424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the pertussis resurgence in England and Wales, and options for future control.
    Choi YH; Campbell H; Amirthalingam G; van Hoek AJ; Miller E
    BMC Med; 2016 Sep; 14(1):121. PubMed ID: 27580649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the cost-effectiveness of maternal acellular pertussis immunization (aP) in different socioeconomic settings: A dynamic transmission model of pertussis in three Brazilian states.
    Luz PM; Struchiner CJ; Kim SY; Minamisava R; Andrade ALS; Sanderson C; Russell LB; Toscano CM
    Vaccine; 2021 Jan; 39(1):125-136. PubMed ID: 33303180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infant Hospitalizations and Fatalities Averted by the Maternal Pertussis Vaccination Program in England, 2012-2017: Post-implementation Economic Evaluation.
    Sandmann F; Jit M; Andrews N; Buckley HL; Campbell H; Ribeiro S; Sile B; Stowe J; Tessier E; Ramsay M; Choi YH; Amirthalingam G
    Clin Infect Dis; 2020 Nov; 71(8):1984-1987. PubMed ID: 32095810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of a pertussis vaccination programme for Japan considering intergenerational infection.
    Itatani T; Shimizu S; Iwasa M; Ohkusa Y; Hayakawa K
    Vaccine; 2013 Jun; 31(27):2891-7. PubMed ID: 23570987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.